Michael Winlo

Michael Winlo

Chief Tech/Sci/R&D Officer at EMYRIA LIMITED

Net worth: 89 266 $ as of 30/06/2026

Consumer Services
Electronic Technology
Health Technology

Profile

Michael Winlo is the founder of Cerulean Medical Pty Ltd., founded in 2007.
Dr. Winlo is currently Non-Executive Director at Nanoveu Ltd. since 2023 and Executive Director & Chief Scientific Officer at Emyria Ltd. starting in 2025.
Former positions include Director at Linear Clinical Research Ltd. from 2019 to 2024 and Non-Executive Director at dorsaVi Ltd. from 2023 to 2025.
Education includes an MBA from Stanford University and an undergraduate degree from The University of Western Australia Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/12/2025 23,86,154 ( 0.22% ) 89 266 $ 30/06/2026

Michael Winlo active positions

CompaniesPositionStart
EMYRIA LIMITED Chief Tech/Sci/R&D Officer 22/01/2025
NANOVEU LIMITED Director/Board Member 28/03/2023

Former positions of Michael Winlo

CompaniesPositionEnd
DORSAVI LTD Director/Board Member 04/07/2025
Linear Clinical Research Ltd.
Chief Executive Officer 01/10/2019
Founder -
See the detail of Michael Winlo's experience

Training of Michael Winlo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

3

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Electronic Technology

Linear Clinical Research Ltd.

Consumer Services

Health Technology

Electronic Technology

Technology Services